Professor, Oncology, Mayo Medical School
Oncology
Dr. Lynn C. Hartmann, MD
|
|
Give Review
Dr. Lynn C. Hartmann practices Oncology. She graduated from Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19/29 in Research/PrimaryCare. She has 1 awards "Whos Who in Medicine and Healthcare". Lynn C. Hartmann is a published physician. She has 101 papers published. The most current publication "Natural history of age-related lobular involution and impact on breast cancer risk."
Publications
- Mucocele-like lesions of the Breast: a clinical outcome and histologic analysis of 102 cases.
- Natural history of age-related lobular involution and impact on Breast cancer risk.
- ERβ Expression and Breast Cancer Risk Prediction for Women with Atypias.
- Clinicopathologic features of Breast cancers that develop in women with previous benign Breast disease.
- Reply to M.H. Gail et al.
- Assessment of published models and prognostic variables in epithelial ovarian Cancer at Mayo Clinic.
- Model for individualized prediction of Breast cancer risk after a benign Breast biopsy.
- Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian Cancer.
- Flat epithelial atypia and risk of Breast cancer: A Mayo cohort study.
- Atypical hyperplasia of the Breast--risk assessment and management options.
- A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors.
- Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian Cancer.
- Impact of Reconstruction and Reoperation on Long-Term Patient-Reported Satisfaction After Contralateral Prophylactic Mastectomy.
- Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian Cancer.
- Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian Cancer outcome.
- Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study.
- Sclerosing adenosis and risk of Breast cancer.
- APOBEC3B Upregulation and Genomic Mutation Patterns in Serous Ovarian Carcinoma.
- The use of CT findings to predict extent of tumor at primary surgery for ovarian Cancer.
- Nutritional status, CT body composition measures and survival in ovarian Cancer.
- Inherited variants in regulatory T cell genes and outcome of ovarian Cancer.
- Benign Breast Disease and the Risk of Subsequent Breast Cancer in African American Women.
- Fracture risk in women with Breast cancer: A population-based study.
- Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and...
- Prophylactic and Therapeutic Mastectomy in BRCA Mutation Carriers: Can the Nipple Be Preserved?
- Lobular neoplasia: how to manage with partial understanding.
- p16INK4a expression and Breast cancer risk in women with atypical hyperplasia.
- Histologic findings in normal Breast tissues: comparison to reduction mammaplasty and benign Breast disease tissues.
- Tissue composition of mammographically dense and non-dense Breast tissue.
- Assessment of hepatocyte growth factor in ovarian Cancer mortality.
- Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma.
- Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian Cancer.
- Estrogen receptor expression in atypical hyperplasia: lack of association with Breast cancer.
- Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary.
- Polymorphisms in ABCB1 and ERCC2 associated with ovarian Cancer outcome.
- Pseudoangiomatous stromal hyperplasia and Breast cancer risk.
- Independent association of lobular involution and mammographic Breast density with Breast cancer risk.
- Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of Breast cancer.
- Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for Breast cancer risk prediction in women with atypical hyperplasia.
- Ovarian Cancer care: it's time for "personalized" approaches.
- Association between mammographic density and age-related lobular involution of the Breast.
- Inherited determinants of ovarian Cancer survival.
- A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.
- Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian Cancer.
- Risk of ovarian Cancer and inherited variants in relapse-associated genes.
- Novel Breast tissue feature strongly associated with risk of Breast cancer.
- Menstrual cycle and surgical treatment of Breast cancer: findings from the NCCTG N9431 study.
- Polymorphisms in TCEAL7 and risk of epithelial ovarian Cancer.
- Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian Cancer.
- Mammary involution and Breast cancer risk: transgenic models and clinical studies.
- Immune-induced epithelial to mesenchymal transition in vivo generates Breast cancer stem cells.
- Functional folate receptor alpha is elevated in the blood of ovarian Cancer patients.
- Assessment of the accuracy of the Gail model in women with atypical hyperplasia.
- Proceedings of the international consensus conference on Breast cancer risk, genetics, & risk management, April, 2007.
- Quantitation of circulating tumor cells in blood samples from ovarian and prostate Cancer patients using tumor-specific fluorescent ligands.
- An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with Cancer.
- Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of Breast cancer.
- Folate receptor alpha as a tumor target in epithelial ovarian Cancer.
- Relative weight at age 12 and risk of postmenopausal Breast cancer.
- Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian Cancer.
- Immunomagnetic diffractometry for detection of diagnostic serum markers.
- Molecular pathogenesis and therapeutic targets in epithelial ovarian Cancer.
- Folate receptor overexpression is associated with poor outcome in Breast cancer.
- In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry.
- Stratification of Breast cancer risk in women with atypia: a Mayo cohort study.
- Current management strategies for ovarian Cancer.
- Benign Breast disease: emerging findings in a diverse population.
- Recreational physical activity and risk of postmenopausal Breast cancer based on hormone receptor status.
- Age-related lobular involution and risk of Breast cancer.
- The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian Cancer.
- Helping people cope with bereavement: an opportunity for health care providers to link Web-based resources across Minnesota.
- T-cell immunity to the folate receptor alpha is prevalent in women with Breast or ovarian cancer.
- Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.
- An analysis of Breast cancer risk in women with single, multiple, and atypical papilloma.
- Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.
- Estrogen bioactivation, genetic polymorphisms, and ovarian Cancer.
- Independent test set performance in the prediction of early relapse in ovarian Cancer with gene expression profiles.
- Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central Cancer treatment group.
- Breast biopsy utilization: a population-based study.
- Benign Breast disease and the risk of Breast cancer.
- Unrealistic expectations.
- Elevated fibroblast growth factor 23 in women with malignant ovarian tumors.
- Gene expression profiles predict early relapse in ovarian Cancer after platinum-paclitaxel chemotherapy.
- A piece of my mind. The octogenarian's plan.
- Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.
- ERBB2, TBX2, RPS6KB1, and MYC alterations in Breast tissues of BRCA1 and BRCA2 mutation carriers.
- Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian Cancer.
- Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions.
- Long-term follow-up of women with ovarian Cancer after positive second-look laparotomy.
- Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines.
- Microsatellite instability in hereditary and sporadic Breast cancers.
- Reoperations after prophylactic mastectomy with or without implant reconstruction.
- Stories of Breast cancer through art.
- Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian Cancer.
- Risk of Breast cancer and Breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience.
- Her-2/neu expression in ovarian Cancer: pre- and postexposure to platinum chemotherapy.
- Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.
- Pathologic characteristics of Breast parenchyma in patients with hereditary Breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
- Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisp...
- Current status of prophylactic mastectomy.
Schools
Northwestern University The Feinberg School Of Medicine
University Ia HospsClins
Mayo Med Fdn
Conditions Treated
- Breast Cancer
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
Mayo School of Graduate Medical Education -
University of Iowa Hospitals and Clinics -
Northwestern University Feinberg School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Similar Doctors
|
|
Dr. Jan C. Buckner, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kiernan J. Minehan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yolanda I. Garces, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Rubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James N. Ingle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael G. Haddock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert B. Diasio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katharine A. Price, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rakhee R. Vaidya, MD
This Doctor is OpenDoctor Recommended.
|